Search clinical trials for: Fat Quantification Liver

Total 62376 results

National Taiwan University Hospital
National Taiwan University

Recruiting

Using Hydroxychloroquine to Treat Nonalcoholic Steatohepatitis

Nonalcoholic Steatohepatitis

Taiwan
Tanta University

Not yet recruiting

Comparative Clinical Study to Evaluate the Efficacy and Safety of Rosuvastatin Vs CoQ10 on Nonalcoholic Steatohepatitis

Nonalcoholic Steatohepatitis
Columbia University
University of California, Berkeley

Recruiting

Glycemic Effect of Diazoxide in NAFLD

Insulin Resistance | Prediabetic State | Hyperinsulinemia | Non-Alcoholic Fatty Liver Disease

United States
Brigham and Women's Hospital

Recruiting

Endoscopic Ultrasound Shear Wave Elastography in Patients With Non-alcoholic Fatty Liver Disease

Obesity | Non-Alcoholic Fatty Liver Disease | Non-alcoholic Steatohepatitis

United States
Sun Yat-sen University

Recruiting

FOLFOX Via HAI Plus Intravenous Irinotecan With or Without Bevacizumab Versus Systemic FOLFOXIRI With or Without Bevacizumab in Initially Unresectable RAS-mutated CRLM Patients

Colorectal Cancer Metastatic

China
Columbia University
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); Albert...

Recruiting

Pancreatic Clamp in NAFLD

Obesity | Insulin Resistance | Prediabetic State | Hyperinsulinemia | Non-Alcoholic Fatty Liver Disease

United States
University of Turin, Italy
Gilead Sciences

Recruiting

Burden of Hepatitis D Virus (HDV) Infection in Italy (HDV Describe)

Chronic Hepatitis D

Italy
Nanfang Hospital of Southern Medical University

Recruiting

A Bidirectional Study in Exploring the Dynamic Changes of Plasma and Urine Metabolites of Liver Cancer

Liver Cirrhosis | Hepatitis | Fatty Liver | Liver Cancer

China
Virginia Commonwealth University
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Recruiting

Predicting Outcomes in Nonalcoholic Steatohepatitis With Advanced Fibrosis

Nonalcoholic Steatohepatitis

United States
Duke University

Recruiting

A Feasibility Trial of OCM Supplements for the Treatment of NAFLD

NAFLD

United States
Sun Yat-sen University

Recruiting

A Study of the Application of HAIC in Advanced HCC Previously Treated With ICIs and Antiangiogenic Agents

Hepatocellular Carcinoma

China
Tongji Hospital
The Second Affiliated Hospital of Fujian Medical University; Geneplus-Beijing... and other collaborators

Recruiting

Combined TACE, TKI/Anti-VEGF and ICIs as Conversion Therapy for Advanced Hepatocellular Carcinoma (CCGLC-008)

Hepatocellular Carcinoma Non-resectable

China
Wan-Guang Zhang
The Second Affiliated Hospital of Fujian Medical University; Geneplus-Beijing... and other collaborators

Recruiting

Combined HAIC, TKI/Anti-VEGF and ICIs as Conversion Therapy for Unresectable Hepatocellular Carcinoma (CCGLC-001)

Hepatocellular Carcinoma Non-resectable

China
Academisch Medisch Centrum - Universiteit van Amsterdam...
Radboud University Medical Center; Leiden University Medical Center; Maag Lever...

Recruiting

The Nijmegen-Leiden-Amsterdam 2-tiered Care Path Study (NLA2)

Non-Alcoholic Fatty Liver Disease

Netherlands
BeiGene

Recruiting

A Study to Evaluate the Safety and Efficacy of Zanubrutinib in Participants With Primary Membranous Nephropathy

Primary Membranous Nephropathy

China, United Kingdom, United States
University of North Carolina, Chapel Hill
Albert Einstein College of Medicine; Abbott; Doris Duke Charitable Foundation; Université...

Recruiting

The COMBAT HBV Feasibility Trial (COMBAT-HBV)

Hepatitis B | Vertical Transmission of Infectious Disease

Congo, The Democratic Republic of the
Azienda Ospedaliera Universitaria Integrata Verona

Not yet recruiting

The Study Aims to Investigate the Effects of Oral Inositols on Insulin-resistance in Children With Obesity. (ONIRICO)

Obesity | Insulin Resistance | Dyslipidemias | Prediabetic State
Zhujiang Hospital

Recruiting

Applicability of 3D-HDRA in Patients With Primary Liver Cancer: A Randomized Controlled Trial

Liver, Cancer of, Primary Resectable

China
University Hospital, Angers

Recruiting

Screening in Primary Care of Advanced Liver Fibrosis in NAFLD and/or Alcoholic Patients (SOPRANO)

Liver Fibrosis | Non-alcoholic Fatty Liver Disease (NAFLD) | Alcoholic Liver Disease (ALD)

France
King Saud University
King Fahad Medical City

Recruiting

Non-Alcoholic Fatty Liver Disease in a Saudi Cohort With Type 2 Diabetes Mellitus (CORDIAL)

Type 2 Diabetes Mellitus | Nonalcoholic Fatty Liver Disease

Saudi Arabia
Institute of Liver and Biliary Sciences, India

Recruiting

Effect of Indian Hepatoprotective Diet in Reversibility of NAFLD (NAFLDNutrition)

Metabolic Syndrome | Non-Alcoholic Fatty Liver Disease

India
Massachusetts General Hospital
National Cancer Institute (NCI); National Institutes of Health (NIH)

Recruiting

COffee and Metabolites Modulating the Gut MicrobiomE in Colorectal caNCER (COMMENCER)

Colorectal Cancer | Fibrosis, Liver | Stenosis | Gastrointestinal Microbiome | Coffee | Ultrasound Elastography | Proton Magnetic Resonance Spectroscopy

United States
Guangdong Raynovent Biotech Co., Ltd

Recruiting

A Randomized, Double-blind, Placebo-controlled Study of ZSP1601 in Adult Subjects With Nonalcoholic Steatohepatitis (NASH)

Nonalcoholic Steatohepatitis (NASH)

China
National Taiwan University Hospital
Taipei Medical University Hospital

Not yet recruiting

Investigation on Safety and Efficacy of Soybean Fermented Extract (MBS217) in Treating Patients With NAFLD

Non-Alcoholic Fatty Liver Disease
Oasis Pharmaceuticals, LLC
Mayo Clinic; National Institute of Diabetes and Digestive and Kidney Diseases...

Recruiting

Safety Study of OA-235i in Subjects With Nonalcoholic Steatohepatitis

Nonalcoholic Steatohepatitis | Nonalcoholic Fatty Liver

United States
Sohag University

Not yet recruiting

Hepatic Steatosis and Fibrosis in Rheumatoid Arthritis Patients

Hepatic Steatosis and Fibrosis in Rheumatoid Arthritis Patients
Federation Francophone de Cancerologie Digestive

Not yet recruiting

Study Evaluating the Benefit of Adding Ipilimumab to the Combination of Atezolizumab and Bevacizumab in Patients With Hepatocellular Carcinoma Receiving First-line Systemic Therapy (TRIPLET)

Metastatic Cancer | Metastatic Tumor | HCC - Hepatocellular Carcinoma

France
Aadi Bioscience, Inc.

Recruiting

Dose-escalation Study to Assess Safety and Pharmacokinetics of Nab-Sirolimus in Patients With Locally Advanced or Metastatic Solid Tumors and Moderate Liver Impairment

Advanced Solid Tumor | Tumor | Tumor, Solid

United States
Institute of Hematology & Blood Diseases Hospital

Recruiting

Pediatric-inspired Regimen Combined With Venetoclax for Adolescent and Adult Patients With de Novo Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia

Precursor Cell Lymphoblastic Leukemia-Lymphoma

China
Memorial Sloan Kettering Cancer Center

Recruiting

A Study of Targeted Radiation Therapy in People With Non-Small Cell Lung Cancer (NSCLC)

NSCLC | Non Small Cell Lung Cancer | Non Small Cell Lung Cancer Metastatic | NSCLC Stage IV | Non-small Cell Carcinoma

United States
Tasly Biopharmaceuticals Co., Ltd.

Recruiting

A Trial to Evaluate the Safety Tolerability and Pharmacokinetics of B1344 by Subcutaneous Injection in Healthy Subjects

Nonalcoholic Steatohepatitis

United States
Charite University, Berlin, Germany
Wilhelm-Doerenkamp-Foundation (Funding)

Recruiting

Nutraceutical Improvement of Glucose Metabolism, NAFLD and Insulin Resistance by Oat-fiber Supplementation in Type 2 Diabetes Mellitus Patients (NIMROD)

Type 2 Diabetes | NAFLD

Germany
University Hospital, Toulouse

Recruiting

Porphyromonas Gingivalis and Severity of Fibrosis in Patients With Non-alcoholic Fatty Liver Disease (BUCCONAFLD)

Non-Alcoholic Fatty Liver Disease

France
Julius Clinical
UMC Utrecht; Erasmus Medical Center; Sint Franciscus Gasthuis

Not yet recruiting

Global Research Initiative for Patients Screening on NASH (GRIP on NASH)

Obesity | Metabolic Syndrome | Type 2 Diabetes | NAFLD | Fibrosis, Liver | Arterial Hypertension | NASH | NASH With Fibrosis | Steatosis of Liver
Regeneron Pharmaceuticals

Recruiting

A Trial to Learn if ALN-PNP is Safe and Well Tolerated in Healthy Adults and Adult Participants With Non-Alcoholic Fatty Liver Disease (NAFLD)

Healthy Volunteers | Non-alcoholic Fatty Liver Disease (NAFLD)

United States
Assistance Publique - Hôpitaux de Paris

Not yet recruiting

Hepatitis C in Prison: Study of Screening and Rapid Treatment (HEPAPRIS) (HEPAPRIS)

Chronic HIV Infection

France
Alexion Pharmaceuticals, Inc.

Recruiting

Evaluation of Pharmacokinetics, Pharmacodynamics, Efficacy, Safety, and Immunogenicity of Ravulizumab Administered Intravenously in Pediatric Participants With Generalized Myasthenia Gravis (gMG)

Generalized Myasthenia Gravis | gMG

Spain, Italy, United States, France, Switzerland, Serbia, Japan, Netherlands
Getz Pharma

Not yet recruiting

Effect of Erugliflozin On Liver Fat, Liver Fibrosis and Glycemic Control in Type II DM Patients With NASH/NAFLD (Ertu-NASH)

Body Weight Changes | Liver Fat | Tolerance | Liver Fibrosis | Glycemic Control | Waist Circumference
Hvidovre University Hospital
University of Copenhagen Danish Research Centre for Magnetic Resonance; Nutrition...

Not yet recruiting

The Acute Effects of Eucaloric and Hypocaloric Carbohydrate Restriction on Liver Fat Content and Metabolism in Obese Individuals (FixedCarb)

Diabetes | Metabolic Syndrome | NAFLD | Overweight and Obesity
Hoffmann-La Roche

Recruiting

A Study to Investigate Vamikibart in Participants With Uveitic Macular Edema (Meerkat)

Uveitic Macular Edema

United States, Korea, Republic of, United Kingdom, China, Netherlands, Canada, Israel, Austria, Brazil, Italy, Taiwan, Poland, Portugal, Mexico
University Hospital, Ghent

Recruiting

Endoscopic Ultrasound-guided Large Diameter Lumen-apposing Metal Stent Gastro-gastrostomy for Bypass Reversal in Patients With Roux-en-y Gastric Bypass (LABOR)

Hypoglycemia | Gastric Outlet Obstruction | Steatohepatitis | Gastric Bypass | Parenteral Support

Belgium
Novo Nordisk A/S

Recruiting

A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With Heart Failure and Inflammation (HERMES)

Heart Failure

Korea, Republic of, Belgium, United States, Australia, Italy, China, Latvia, United Kingdom, Croatia, Spain, Netherlands, Serbia, Malaysia, Israel, Austria, Singapore, Thailand, Hungary, Argentina, Japan, Taiwan, Turkey, Germany, South... and more
Taipei Medical University
TCI Co., Ltd.

Recruiting

Effects of Bacillus Coagulans on Liver and Gut Microbiota Function in NAFLD

Effects of Bacillus Coagulans TCI711 Supplementation on Liver and Gut Microbiota Function in Non-alcoholic Fatty Liver Disease Patients

Taiwan
Tasly Pharmaceutical Group Co., Ltd

Recruiting

HuHuangLianzonggan Capsule in Subjects With Nonalcoholic Steatohepatitis: a Phase 2 tRial(HHL-HEPAR)

NASH

China
Xiangya Hospital of Central South University

Recruiting

Observational Study About Patients Diagnosed With NAFLD

Nonalcoholic Fatty Liver Disease

China
Institut National de la Santé Et de la Recherche...
Centre Hospitalier Universitaire de Nice

Not yet recruiting

CHronic Hepatopathies Associated With ALcohol Consumption aNd metAbolic Syndrome (CHALNA2)

Hepatocellular Carcinoma | Cirrhosis, Liver | Non-Alcoholic Fatty Liver Disease | Non-Alcoholic Steatohepatitis | Alcohol-related Liver Disease
Cairo University

Recruiting

Liver Enzymes and Metabolic Risk Factors Response to Laser Acupuncture Versus Cupping Therapy in Fatty Liver

Fatty Liver

Egypt
Instituto de Investigación Marqués de Valdecilla

Not yet recruiting

Evaluate the Efficacy, Safety and Tolerability of Fecal Microbiota Transfer for the Treatment of Patients With Nonalcoholic Steatohepatitis (EMOTION)

Patients With Nonalcoholic Steatohepatitis
Henan Cancer Hospital

Recruiting

Lenvatinib for Advanced Bone and Soft Tissue Sarcoma

Sexuality | Effectiveness

China
Pontificia Universidad Catolica de Chile

Recruiting

Prevention of NAFLD and CVD Through Lifestyle Intervention (MAUCO+)

Non-Alcoholic Fatty Liver Disease | Gallstone Disease

Chile

Search clinical trials for: Fat Quantification Liver

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Belgium

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations